Table 1 Rheumatoid arthritis patients with active or stable, well controlled disease and control individuals
From: Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia
Parameter | Controls | Active RA | OA | RA in remission |
|---|---|---|---|---|
n | 34 | 28 | 12 | 36 |
Age (mean ± standard deviation [range]; years) | 48 ± 16 (24–62) | 51 ± 17 (20–83) | 60 ± 9 (49–73) | 48 ± 11 (25–67) |
Sex (male/female) | 6/17 | 9/28 | 3/9 | 7/29 |
Disease duration (mean ± standard deviation [range]; years) | NA | 5.1 ± 7.5 (0.1–37) | NA | 9.3 ± 6.8 (2–28) |
Remission duration (mean ± standard error [range]; months) | NA | NA | NA | 29 ± 29 (6–144) |
CRP (mean ± standard deviation [range]; mg/l), below /above detectiona | NA | 55 ± 52 (5–164), 0/28 | NA | 3.5 ± 5.2 (0–12), 23/13 |